-
Loading metrics
Open Access
Peer-reviewed
Research Article
Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
-
Sandhya Vasan ,
* E-mail: svasan@adarc.org
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Sarah J. Schlesinger,
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Yaoxing Huang,
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Arlene Hurley,
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Angela Lombardo,
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Zhiwei Chen,
Current address: AIDS Institute, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, People's Republic of China
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Soe Than,
Current address: Pfizer Inc, New York, New York, United States of America
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Phumla Adesanya,
Current address: Novartis Pharmaceuticals, Basel, Switzerland
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Catherine Bunce,
Affiliation University of Rochester Medical Center, Rochester, New York, United States of America
⨯ -
Mark Boaz,
Current address: Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Rosanne Boyle,
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Eddy Sayeed,
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Lorna Clark,
Affiliation International AIDS Vaccine Initiative Core Laboratory, Imperial College, London, United Kingdom
⨯ -
Daniel Dugin,
Affiliation Aaron Diamond AIDS Research Center, New York, New York, United States of America
⨯ -
Claudia Schmidt,
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ -
Yang Song,
Affiliation Aaron Diamond AIDS Research Center, New York, New York, United States of America
⨯ -
Laura Seamons,
Affiliation International AIDS Vaccine Initiative Core Laboratory, Imperial College, London, United Kingdom
⨯ -
Len Dally,
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Martin Ho,
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Carol Smith,
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
⨯ -
Martin Markowitz,
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ -
Josephine Cox,
Affiliation International AIDS Vaccine Initiative Core Laboratory, Imperial College, London, United Kingdom
⨯ -
Dilbinder K. Gill,
Affiliation International AIDS Vaccine Initiative Core Laboratory, Imperial College, London, United Kingdom
⨯ -
Jill Gilmour,
Affiliation International AIDS Vaccine Initiative Core Laboratory, Imperial College, London, United Kingdom
⨯ -
Michael C. Keefer,
Affiliation University of Rochester Medical Center, Rochester, New York, United States of America
⨯ -
Patricia Fast,
Affiliation International AIDS Vaccine Initiative, New York, New York, United States of America
⨯ - [ ... ],
-
David D. Ho
Affiliations Aaron Diamond AIDS Research Center, New York, New York, United States of America, The Rockefeller University, New York, New York, United States of America
⨯ - [ view all ]
- [ view less ]
Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine
- Sandhya Vasan,
- Sarah J. Schlesinger,
- Yaoxing Huang,
- Arlene Hurley,
- Angela Lombardo,
- Zhiwei Chen,
- Soe Than,
- Phumla Adesanya,
- Catherine Bunce,
- Mark Boaz
- Published: January 25, 2010
- https://doi.org/10.1371/journal.pone.0008617